References
- Reddy VP and Beyaz A. Inhibitors of the Maillard reaction and AGE breakers as therapeutics for multiple diseases. Drug Discovery Today 2006;11:13–14.
- Sakai M, Oimomi M and Kasuga M, Kobe J. Experimental studies on the role of fructose in the development of diabetic complications. Med Sci 2002;48:125–136.
- Singh R, Barden A, Mori T, Beilin L. Advanced glycation end-products: a review. Diabetologia 2001;44:129–146.
- Bendayan M. Immunocytochemical detection of advanced glycated endproducts in rat renal tissues as a function of age and diabetes. Kidney Int 1998;54:438–447.
- Vlassara H. Advanced glycation in health and disease: role of the modern environment. Ann NY Acad Sci 2005;1043:452–460.
- Wautier JL, Guillausseau PJ. Advanced glycation endproducts, their receptors and diabetic angiopathy. Diabetes Metab (Paris) 2001;27:535–542.
- Atta-ur-Rahman Choudhary, MI, Basha FZ, Abbas G, Khan SN, Ali S. A, Science at the interface of chemistry and biology: Discoveries of α-glucosidase inhibitors and antiglycation agents. Pure Appl Chem. 2007;79:2263– 2268.
- Kern TS, Engerman RL. Pharmacological inhibition of diabetic retinopathy aminoguanidine and aspirin. Diabetes 2001;50:1636–1642.
- Sell DR, Nelson JF, Monnier VM. Longitudinal determination of skin collagen glycation and glycoxidation rates predicts early death in C57BL/6NNIA mice. J Gerontol (A Biol Sci Med Sci) 2001;56:B405–B411.
- Taguchi T, Sugiura M, Hamada Y, Miwa I. Inhibition of advanced protein glycation by a Schiff base between aminoguanidine and pyridoxal. Eur J Pharmacol 1999;378: 283–289.
- Khan KM, Mughal UR, Ambreen N, Khan A, Perveen S, Choudhary MI. Schiff Bases of Istain: Antiglycation activity. Lett Drug Des Discov 2009;6:358–362.
- Laurean DC, Schramm DD, Jacobson EL, Halaweish I, Bruckner GG, Boissonneault GA. Inhibition of advanced glycation end product formation on collagen by rutin and its metabolites. J Nutr Biochem 2006;17:531–40.
- Wu CH, Yen GC. Inhibitory effect of naturally occurring flavonoids on the formation of advanced glycation endproducts. J Agric Food Chem 2005;20:3167–73.
- Choudhary MI, Jan S, Abbaskhan A, Musharraf SG, Samreen Sattar, SA, Atta-ur-Rahman. Cycloartane triterpenoids from Astragalus bicuspis. J Nat Prod 2008;71:1557–1560.
- Matsuda H, Wang T, Managi H, Yoshikawa M. Structural requirements of flavonoids for inhibition of protein glycation and radical scavenging activities. Bioorg Med Chem 2003;11:5317–5323.
- Duraisamy Y, Gaffney J, Selvin M, Smith CA, Williamson K, Ahmed N. Aminosalicylic acid reduces the antiproliferative effect of hyperglycaemia, advanced glycation endproducts and glycated basic fibroblast growth factor in cultured bovine aortic endothelial cells: Comparison with aminoguanidine. Mol Cell Biochem 2003;246:143–153.
- Matsuura N, Aradate T, Sasaki C, Kojima H, Ohara M, Hasegawa J, Ubukata M. Screening system for the Maillard reaction inhibitor from natural products extracts. J Health Sci 2002;48:520–526.
- Nakagawa T, Yokozawa T, Terasawa K, Shu S, Juneja LR. Protective activity of green tea against free radical- and glucose-mediated protein damage. J Agric Food Chem 2002;50:2418–2422.
- Nicholl ID, Bucala R. Advanced glycation endproducts and cigarette smoking. Cell Mol Biol 1998;44:1025–1033.
- Kim HY, Kim K. Protein glycation inhibitory and antioxidative activities of some plant extracts in vitro. J Agric Food Chem 2003;51:1586–1591.
- Kara D, Alkan M. Preconcentration and separation of copper (II) with solvent extraction using N,N′-bis(2-hydroxy-5-bromo-benzyl)1,2 diaminopropane. Microchem J 2002;71:29–39.